Patent · US Active

Peptide nucleic acid based guanidinium compounds

US7700565B2 · kind B2 · utility

0Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2006
Grant dateApr 20, 2010
Priority date
Expiry dateAug 18, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are transmembrane transporter compounds containing guanidinium groups to enhance transport of a polymer backbone across biomembranes. Therapeutic and other biologically active moieties may be attached to the compounds. The polymer backbone may include peptide nucleic acid monomer units.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.